Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Working Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 3.162.692.662.943.12

What is the latest Working Capital/Sales ratio of NGL FINECHEM ?

The latest Working Capital/Sales ratio of NGL FINECHEM is 3.16 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20253.16
Mar20242.69
Mar20232.66
Mar20222.94
Mar20213.12

How is Working Capital/Sales of NGL FINECHEM Trending?

Years Working Capital/Sales % Change
Mar2025 3.16
17.47
Mar2024 2.69
1.13
Mar2023 2.66
-9.52
Mar2022 2.94
-5.77
Mar2021 3.12 -

Other Financial Ratios of NGL FINECHEM


Compare Working Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹880.8 Cr -5.4% 16.7% -34.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,197.0 Cr 0.9% -0.2% -12.5% Stock Analytics
DIVIS LABORATORIES ₹159,634.0 Cr 0.1% 0.4% 16.6% Stock Analytics
CIPLA ₹126,082.0 Cr 0.5% 3.8% -3.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,167.0 Cr NA -0.9% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,783.0 Cr 2.8% 6.9% -2% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-5.4%

16.7%

-34.8%

SENSEX

1%

2.1%

0.5%


You may also like the below Video Courses